FDA Awards Priority Review Voucher to Alexion Pharmaceuticals for Rare Pediatric Disease Product

Summary

The FDA has issued a priority review voucher to Alexion Pharmaceuticals, the manufacturer of KANUMA, a rare pediatric disease product, following a review of the product's eligibility under the FD&C Act and FDASIA.